Results for tag: "Omega 3 Prescription Drugs"

Within the pharmaceutical sector, the market for prescription Omega-3 drugs consists of medications designed to treat high triglyceride levels, a type of fat found in the blood. These drugs are composed of highly purified and concentrated Omega-3 fatty acids, which are typically derived from fish oil. The primary components effective in these treatments are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Typically, these medications are part of a broader treatment plan that includes diet and lifestyle changes for patients with lipid disorders. Prescription Omega-3 products differ from over-the-counter fish oil supplements in that they contain precise dosages of EPA and DHA and must meet stringent FDA regulations for purity, strength, and manufacturing practices. The benefits of these drugs are supported by clinical research, showing their efficacy in reducing elevated triglyceride levels, which is associated with an increased risk of cardiovascular events. Several pharmaceutical companies operate within the prescription Omega-3 market. Notable players include Amarin Corporation with their drug Vascepa, which is rich in EPA. AstraZeneca is another key company with Epanova, a combination of EPA and DHA. GlaxoSmithKline offers Lovaza, containing both fatty acids, while Matinas BioPharma is pursuing the development of novel formulations in this market with their drug MAT9001. Show Less Read more